scispace - formally typeset
Z

Zhengdong Cai

Researcher at Shanghai Jiao Tong University

Publications -  111
Citations -  3412

Zhengdong Cai is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Osteosarcoma & Apoptosis. The author has an hindex of 28, co-authored 97 publications receiving 2403 citations. Previous affiliations of Zhengdong Cai include Tongji University & Second Military Medical University.

Papers
More filters
Journal ArticleDOI

Immunogenic cell death in cancer therapy: Present and emerging inducers.

TL;DR: This review discussed and summarized the emerging methods for inducing immunogenic cancer cell death and concepts and molecular mechanisms relevant to antitumour effects of ICD are also briefly discussed.
Journal ArticleDOI

The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis

TL;DR: Shikonin had prompt but profound anti-tumor effect on both primary and metastatic osteosarcoma, probably by inducing RIP1 and RIP3 dependent necroptosis.
Journal ArticleDOI

Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo.

TL;DR: Erianin may be a promising agent for anticancer therapy against OS through induced cell cycle G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human OS.
Journal ArticleDOI

Comparison of clinical outcome between simultaneous-bilateral and staged-bilateral total knee arthroplasty: a systematic review of retrospective studies.

TL;DR: Pooled results showed that the prevalence of mortality at 30 days postoperatively, pulmonary embolism, blood transfusion rate were significantly higher in simultaneous TKA group, while a significantly lower rate of deep infection and revision were found in simultaneously TKA.